HIRA-mediated H3.3 deposition is required for de novo paternal nuclear envelope formation in mouse zygotes by Inoue, Azusa & Zhang, Yi
 
HIRA-mediated H3.3 deposition is required for de novo paternal
nuclear envelope formation in mouse zygotes
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Inoue, Azusa, and Yi Zhang. 2013. HIRA-mediated H3.3
deposition is required for de novo paternal nuclear envelope
formation in mouse zygotes. Epigenetics & Chromatin 6(Suppl
1): O5.
Published Version doi:10.1186/1756-8935-6-S1-O5
Accessed February 19, 2015 12:00:58 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10609732
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAORAL PRESENTATION Open Access
HIRA-mediated H3.3 deposition is required for de
novo paternal nuclear envelope formation in
mouse zygotes
Azusa Inoue
1,2,3*, Yi Zhang
1,2,3
From Epigenetics and Chromatin: Interactions and processes
Boston, MA, USA. 11-13 March 2013
Paternal genome undergoes dynamic chromatin remodel-
ing after fertilization. The first event is the exchange of
protamines with maternally deposited histones including
H3.3. Although HIRA has been shown to be responsible
for H3.3 deposition in invertebrates, whether such func-
tion is conserved in vertebrates is not known. Further-
more, the biological significance of the protamine-histone
exchange is also unknown. To address these questions, we
depleted the maternal pool of HIRA protein by using an in
vitro oocyte growth system where siRNA is injected into
small growing oocytes with surrounding granulose cells.
In HIRA-depleted zygotes, H3.3 is not incorporated into
the paternal genome while protamines are removed, indi-
cating that protamine-removal is uncoupled from H3.3
deposition. Inhibition of H3.3 deposition prevents the de
novo nucleosome assembly and the formation of paternal
pronucleus. Immunostaining of nuclear envelope compo-
nents revealed the lack of Lamin B1 and nuclear pore
complex assembly and the defect in flattening of endoplas-
mic reticulum (ER) sheets, the precursor of nuclear envel-
ope, only in the paternal genome of HIRA-depleted
zygotes. Furthermore, the HIRA-depletion prevented the
localization of Ran, a GTPase required for ER fusion, in
the paternal genome. Together, our results not only pro-
vide the first direct evidence that HIRA is responsible for
H3.3 deposition of the paternal genome in vertebrates, but
also suggest that HIRA-mediated nucleosome assembly is
a pre-requirement for the recruitment of factors, such as
Ran GTPase, involved in ER flattening and nuclear envel-
ope formation during de novo paternal pronucleus
formation.
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